Abstract
Mortality and morbidity from acute myocardial infarction (MI) are much higher in the elderly than in younger patients, creating a greater potential for improving the outcome with aggressive medical therapy. Elderly patients can benefit significantly from early thrombolysis with relatively few complications; aspirin and heparin-particularly in conjunction with thrombolytic agents-are highly effective. Long-term β-blockade can improve survival markedly, and the use of intravenous angiotensin-converting enzyme inhibitors before discharge decreases both mortality and the risk of heart failure. Early results for magnesium sulfate are promising as well.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 29-36 |
| Number of pages | 8 |
| Journal | Drug Therapy |
| Volume | 23 |
| Issue number | 8 |
| State | Published - Jan 1 1993 |
ASJC Scopus subject areas
- Pharmaceutical Science